Interestingly, a selective ASIC3 antagonist, APETx2, was able to markedly reduce bone pain in a murine intratibial multiple myeloma model and decreased excitability of DRG neurons cocultured with human multiple myeloma cells,36 providing functional evidence for the role of ASIC3. Here, ASIC3 is linked to AL amyloidosis.